The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

No abstract available.

Information

Citation

Rzepka AM, Wong L, Chaudhry M, Sproule BA, He N, Cadarette SM. Can Pharm J (Ott). 2022; 155(4):194-9. Epub 2022 Jun 20.

View Source

Discover More

Journal Article

31/08/2026

Building on routinely collected health data for precision population care in inflammatory bowel disease

Postill G, Benchimol EI. Healthc Q. 2026; 29(2): 6-9.

Journal Article

30/08/2026

Comparing administrative data and resident assessment instrument data for mental health surveillance in home care and long-term care populations

Marrie RA, Bolton JM, Chen X, Dvorani E, Ekuma O, Goodarzi Z, Gruneir A, Luo J, Herrmann N, Hoben M, Hogan DB, Iaboni A, Seitz D, Walld R, Wodchis WP, Maxwell CJ; EMHLTH‐CC Research Team. Int J Methods Psychiatr Res. 2026; 35(3): e70105.

Journal Article

29/08/2026

Disruption and recovery of type 2 diabetes screening during the COVID-19 pandemic: a population-based interrupted time-series analysis in Ontario, Canada

Fazli GS, Moineddin R, Ling V, Booth GL. Can J Diabetes. 2026; S1499-2671(26): 00168-1. Epub 2026 Aug 29.

See All

The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Sites

Discover More

Building on routinely collected health data for precision population care in inflammatory bowel disease

Comparing administrative data and resident assessment instrument data for mental health surveillance in home care and long-term care populations

Disruption and recovery of type 2 diabetes screening during the COVID-19 pandemic: a population-based interrupted time-series analysis in Ontario, Canada